中国股票策略 - 2025 年第二季度业绩回顾-MSCI 中国符合预期,A 股走弱-China Equity Strategy-2Q25 Earnings Review – MSCI China in Line, A-Shares Soften
2025-09-11 20:11
更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 September 10, 2025 09:00 PM GMT China Equity Strategy | Asia Pacific 2Q25 Earnings Review – MSCI China in Line, A-Shares Soften MSCI China saw its 3rd in-line quarter in a row, A-shares missed on company counts but were in line on weighted surprises, softening vs. 1Q. Comm Services/ Financials led on earnings beats. Pharma & Biotech/Materials saw strong returns with earnings upgrades; Semis rallied despite estimate cuts. Key takeaways from Chinese equities' 2Q25 earnings season ...